Psilocybin
COMP001
Phase 3 small_molecule active
Quick answer
Psilocybin for Treatment Resistant Depression is a Phase 3 program (small_molecule) at Compass Therapeutics with 7 ClinicalTrials.gov record(s).
Program details
- Company
- Compass Therapeutics
- Indication
- Treatment Resistant Depression
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active